Mice deficient in CYP2E1 are protected from HFD-induced insulin resistance, oxidative stress and fibrosis, indicating a direct role of CYP2E1 in NASH and T2DM [62]. The gene discussed is CYP2E1; the disease is metabolic dysfunction-associated steatohepatitis.